Avantax Planning Partners’s Nu Skin NUS Stock Holding History

Avantax Planning Partners’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-8	Closed	-$1K	–	1052
2018 Q1	$1K	Buy	+8	New	+$568	﹤0.01%	1731

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Avantax Planning Partners's NUS Position: Q2 2018 in Review

Avantax Planning Partners sold out of Nu Skin (NUS) in Q2 2018, closing a stake of 8 shares — an estimated $1K sold.

Avantax Planning Partners first reported a position in NUS in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 295 funds tracked by Wall St. Rank hold NUS as of Q2 2018.

Avantax Planning Partners reported no remaining Nu Skin position as of Q2 2018 after selling out during the quarter.
Avantax Planning Partners sold 8 Nu Skin shares in Q2 2018, an estimated $1K.
Avantax Planning Partners first reported a position in Nu Skin in Q1 2018 and held it in 1 quarter.
Avantax Planning Partners's Nu Skin position peaked at $1K in Q1 2018.
295 funds tracked by Wall St. Rank held Nu Skin as of Q2 2018.

Based on Avantax Planning Partners's 13F filing for Q2 2018, filed 13 Aug 2018.